Although the mechanisms underlying the chemotherapy resistance of Por CRC remain unclear, it has been reported that the activity of dihydropyrimidine dehydrogenase, a key metabolic enzyme of 5-fluorouracil, is higher in Por CRC [12]. This evidence concerns the gene DPYD and colorectal carcinoma.